This Government Contract opportunity from Department Of Defense was posted on July 1, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Supply of Pantoprazole DR 40 MG Tablets – 90 Count Bottle

Closed

Federal

Submission Closed08/03/2026, 07:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

Supply of Self-Locking Hexagon Nuts

ASC COMMODITIES DIVISION

POSTED

DEADLINE

Supply of Centrifugal Brake Shoes (NSN 3040997213621)

LSO COMBAT VEHICLES AND ARMAMENT

POSTED

DEADLINE

SNS Pharmaceutical Logistic Replenishment Requirement

Solicitation # 75A50326R00007

The Department of Health and Human Services, through the Administration for Strategic Preparedness and Response, is soliciting proposals under solicitation 75A50326R00007 for the replenishment of expired or expiring pharmaceuticals for the Strategic National Stockpile. This is a full and open competition resulting in a twelve-month Firm Fixed Price contract. The scope includes the procurement of various FDA-approved pharmaceuticals, such as Dopamine Hydrochloride, Norepinephrine, and Morphine Sulfate, with the government reserving the right to increase awarded quantities by up to 20 percent. Deliveries are FOB Destination and may be required at up to nine locations across the contiguous United States and Hawaii. Award decisions will be based on a best-value tradeoff, prioritizing technical capability and past performance significantly over price. Technical evaluation focuses on product compliance, regulatory requirements, and the ability to meet delivery schedules. Strict quality standards are mandated, including adherence to current Good Manufacturing Practice regulations, specific temperature controls between 20C and 25C during storage and transit, and a requirement that products retain at least 90 percent of their FDA-approved shelf life upon receipt. Proposals must be submitted in two volumes by September 18, 2026, including a technical volume, a pricing volume, and a proposal submission worksheet. Large businesses are additionally required to submit subcontracting plans via the SBCX system.

POSTED

DEADLINE

Supply of Povidone-Iodine Topical Solution

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Fluconazole Tablets 150 MG

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Bupivacaine Hydrochloride Injection

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Close Tolerance Bolts (NSN 5306-01-049-4051)

ASC COMMODITIES DIVISION

POSTED

DEADLINE

Supply of Hydroxyzine Hydrochloride Tablets

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Socket Head Cap Screw Supplier

ASC COMMODITIES DIVISION

POSTED

DEADLINE

Supply of Globulin, Rho (D) Immune (USP)

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Permethrin Cream Rinse Manufacturer

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Cefuroxime Axetil Tablets, USP

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

2 days ago

DEADLINE

in 4 days

AI Contract Overview

The contract entails the manufacture and supply of Pantoprazole DR 40 MG Tablets packaged in 90-count bottles, specifically for distribution to DLA and VA customers through Prime Vendor distributors. The work falls under NAICS code 325412, indicating pharmaceutical preparation manufacturing, and is structured as a subcontract within the Department of Defense’s procurement framework administered by DLA Troop Support. The solicitation was posted on July 1, 2026, with proposals due by August 3, 2026, at 7:00 PM Eastern Time, setting a clear timeline for vendor submissions and evaluation. All products must meet required specifications for dosage form, packaging, and compliance with federal supply standards to ensure seamless integration into the government’s pharmaceutical logistics network. The place of performance and point of contact details are not specified, implying flexibility in manufacturing location but requiring adherence to delivery schedules and distribution protocols managed by Prime Vendor channels.